4//SEC Filing
Wagner Heidi L 4
Accession 0001193125-25-314741
CIK 0001631574other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 9:45 PM ET
Size
11.3 KB
Accession
0001193125-25-314741
Insider Transaction Report
Form 4
Wagner Heidi L
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2025-12-08$5.97/sh+7,000$41,790→ 51,930 total - Sale
Ordinary Shares
2025-12-08$13.00/sh−7,000$91,000→ 44,930 total - Exercise/Conversion
Share Option (right to buy)
2025-12-08−14,000→ 7,000 totalExercise: $5.97Exp: 2026-08-16→ Ordinary Shares (14,000 underlying)
Footnotes (2)
- [F1]The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2025.
- [F2]These share options are fully vested.
Documents
Issuer
Wave Life Sciences Ltd.
CIK 0001631574
Entity typeother
Related Parties
1- filerCIK 0001655029
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 9:45 PM ET
- Size
- 11.3 KB